Explore how pnictogens (Group 15 elements) evolved from historical poisons to revolutionary nanomedicines in cancer therapy and diagnostics.
Exploring how protein conformational changes influence cancer drug design, focusing on human aminopeptidase M1 (APN/CD13) inhibitors.